Interplay between NOD1 and TLR4 Receptors in Macrophages: Nonsynergistic Activation of Signaling Pathways Results in Synergistic Induction of Proinflammatory Gene Expression
- PMID: 33846227
- DOI: 10.4049/jimmunol.2000692
Interplay between NOD1 and TLR4 Receptors in Macrophages: Nonsynergistic Activation of Signaling Pathways Results in Synergistic Induction of Proinflammatory Gene Expression
Abstract
Interactions between pattern-recognition receptors shape innate immune responses to pathogens. NOD1 and TLR4 are synergistically interacting receptors playing a pivotal role in the recognition of Gram-negative bacteria. However, mechanisms of their cooperation are poorly understood. It is unclear whether synergy is produced at the level of signaling pathways downstream of NOD1 and TLR4 or at more distal levels such as gene transcription. We analyzed sequential stages of human macrophage activation by a combination of NOD1 and TLR4 agonists (N-acetyl-d-muramyl-l-alanyl-d-isoglutamyl-meso-diaminopimelic acid [M-triDAP] and LPS, respectively). We show that events preceding or not requiring activation of transcription, such as activation of signaling kinases, rapid boost of glycolysis, and most importantly, nuclear translocation of NF-κB, are regulated nonsynergistically. However, at the output of the nucleus, the combination of M-triDAP and LPS synergistically induces expression of a subset of M-triDAP- and LPS-inducible genes, particularly those encoding proinflammatory cytokines (TNF, IL1B, IL6, IL12B, and IL23A). This synergistic response develops between 1 and 4 h of agonist treatment and requires continuous signaling through NOD1. The synergistically regulated genes have a lower basal expression and higher inducibility at 4 h than those regulated nonsynergistically. Both gene subsets include NF-κB-inducible genes. Therefore, activation of the NF-κB pathway does not explain synergistic gene induction, implying involvement of other transcription factors. Inhibition of IKKβ or p38 MAPK lowers agonist-induced TNF mRNA expression but does not abolish synergy. Thus, nonsynergistic activation of NOD1- and TLR4-dependent signaling pathways results in the synergistic induction of a proinflammatory transcriptional program.
Copyright © 2021 by The American Association of Immunologists, Inc.
Similar articles
-
The Role of the p38-MNK-eIF4E Signaling Axis in TNF Production Downstream of the NOD1 Receptor.J Immunol. 2017 Feb 15;198(4):1638-1648. doi: 10.4049/jimmunol.1600467. Epub 2017 Jan 13. J Immunol. 2017. PMID: 28087669
-
Glycolytic reprogramming of macrophages activated by NOD1 and TLR4 agonists: No association with proinflammatory cytokine production in normoxia.J Biol Chem. 2020 Mar 6;295(10):3099-3114. doi: 10.1074/jbc.RA119.010589. Epub 2020 Jan 31. J Biol Chem. 2020. PMID: 32005665 Free PMC article.
-
Expression of TRAF6 and pro-inflammatory cytokines through activation of TLR2, TLR4, NOD1, and NOD2 in human periodontal ligament fibroblasts.Arch Oral Biol. 2011 Oct;56(10):1064-72. doi: 10.1016/j.archoralbio.2011.02.020. Epub 2011 Mar 31. Arch Oral Biol. 2011. PMID: 21457942
-
Synergistic interactions between NOD receptors and TLRs: Mechanisms and clinical implications.J Leukoc Biol. 2019 Apr;105(4):669-680. doi: 10.1002/JLB.2RU0718-290R. Epub 2018 Dec 5. J Leukoc Biol. 2019. PMID: 30517768 Review.
-
Therapeutic targeting of NOD1 receptors.Br J Pharmacol. 2013 Oct;170(3):475-85. doi: 10.1111/bph.12300. Br J Pharmacol. 2013. PMID: 23848281 Free PMC article. Review.
Cited by
-
Polarized Macrophages in Periodontitis: Characteristics, Function, and Molecular Signaling.Front Immunol. 2021 Dec 7;12:763334. doi: 10.3389/fimmu.2021.763334. eCollection 2021. Front Immunol. 2021. PMID: 34950140 Free PMC article. Review.
-
A Bibliometric Analysis of Macrophage Research Associated with Periodontitis Over the Past Two Decades.Int Dent J. 2025 Feb;75(1):363-374. doi: 10.1016/j.identj.2024.11.016. Epub 2024 Dec 12. Int Dent J. 2025. PMID: 39672778 Free PMC article.
-
Inhibition of specific signaling pathways rather than epigenetic silencing of effector genes is the leading mechanism of innate tolerance.Front Immunol. 2023 Jan 26;14:1006002. doi: 10.3389/fimmu.2023.1006002. eCollection 2023. Front Immunol. 2023. PMID: 36776861 Free PMC article.
-
Nucleotide-Binding Oligomerization Domain 1/Toll-Like Receptor 4 Co-Engagement Promotes Non-Specific Immune Response Against K562 Cancer Cells.Front Pharmacol. 2022 Jul 22;13:920928. doi: 10.3389/fphar.2022.920928. eCollection 2022. Front Pharmacol. 2022. PMID: 35935855 Free PMC article.
-
NOD1 and NOD2: Essential Monitoring Partners in the Innate Immune System.Curr Issues Mol Biol. 2024 Aug 28;46(9):9463-9479. doi: 10.3390/cimb46090561. Curr Issues Mol Biol. 2024. PMID: 39329913 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources